Tirzepatide has been studied in clinical trials for type 2 diabetes and weight management, where it was shown to help regulate appetite, improve blood sugar control, and support weight loss when used under medical supervision.
Sublingual tirzepatide, however, is a compounded formulation and is not FDA-approved. It may be prescribed by a licensed provider when medically appropriate and is prepared by licensed compounding pharmacies. Because compounded versions are not reviewed by the FDA, your provider will carefully monitor your treatment to make sure it is safe and suitable for your individual health needs.
Like any medication, tirzepatide may cause side effects. The most common ones include digestive issues such as nausea, vomiting, or upset stomach. These are usually mild and may improve as your body adjusts. More serious side effects are less common but possible. This is why it’s important to use tirzepatide only under the guidance of a healthcare professional who can monitor your progress and manage any potential risks.